These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2348579)

  • 1. [Therapeutic effects of oral dipyridamole on myocardial perfusion and left ventricular function in patients with hypertrophic cardiomyopathy].
    Kihara K
    Kaku Igaku; 1990 Feb; 27(2):107-15. PubMed ID: 2348579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effect of oral dipyridamole on myocardial perfusion and cardiac performance in patients with hypertrophic cardiomyopathy.
    Koga Y; Kihara K; Yamaguchi R; Wada T; Toshima H
    Am Heart J; 1992 Feb; 123(2):433-8. PubMed ID: 1736582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Left ventricular function at rest and during exercise and the effects of propranolol in patients with hypertrophic cardiomyopathy].
    Amano K; Sakamoto T; Sugimoto T
    J Cardiol Suppl; 1987; 16():35-51. PubMed ID: 3509682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypertrophic non-obstructive cardiomyopathy assessed by dipyridamole thallium single photon emission computed tomography: comparisons with hypertrophic cardiomyopathy with a dilated heart].
    Mori T; Suda K; Ohnishi M; Kanoh Y; Shiotani H; Yokota Y; Fujitani K; Fukuzaki H; Maeda K
    J Cardiol; 1987 Mar; 17(1):35-46. PubMed ID: 3501444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dipyridamole on coronary collateralization and myocardial perfusion in patients with ischaemic cardiomyopathy.
    Belardinelli R; Belardinelli L; Shryock JC
    Eur Heart J; 2001 Jul; 22(14):1205-13. PubMed ID: 11440493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of myocardial perfusion abnormalities in patients with apical hypertrophic cardiomyopathy using exercise 201Tl scintigraphy].
    Sugihara H; Taniguchi Y; Ohtsuki K; Umamoto I; Nakazawa T; Shima T; Nakamura T; Azuma A; Kohno Y; Nakagawa M
    Kokyu To Junkan; 1993 Nov; 41(11):1089-93. PubMed ID: 8256050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy.
    Elliott PM; Rosano GM; Gill JS; Poole-Wilson PA; Kaski JC; McKenna WJ
    Heart; 1996 Feb; 75(2):179-83. PubMed ID: 8673758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina].
    Astarita C; Nicolai E; Liguori E; Gambardella S; Rumolo S; Maresca FS
    G Ital Cardiol; 1998 Sep; 28(9):996-1004. PubMed ID: 9788038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of decreased washout rate in hypertrophic cardiomyopathy by exercise Tl-201 myocardial scintigraphy].
    Inoue S; Nezuo S; Tadaoka S; Hasegawa K; Kawahara Y; Kakumae S; Nakamura T; Wada Y; Sawayama T
    Kokyu To Junkan; 1989 Sep; 37(9):1003-7. PubMed ID: 2595128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thallium-201 myocardial imaging during coronary vasodilation induced by oral dipyridamole.
    Gould KL; Sorenson SG; Albro P; Caldwell JH; Chaudhuri T; Hamilton GW
    J Nucl Med; 1986 Jan; 27(1):31-6. PubMed ID: 3941362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography.
    O'Gara PT; Bonow RO; Maron BJ; Damske BA; Van Lingen A; Bacharach SL; Larson SM; Epstein SE
    Circulation; 1987 Dec; 76(6):1214-23. PubMed ID: 3499997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy.
    Bravo PE; Pinheiro A; Higuchi T; Rischpler C; Merrill J; Santaularia-Tomas M; Abraham MR; Wahl RL; Abraham TP; Bengel FM
    J Nucl Med; 2012 Mar; 53(3):407-14. PubMed ID: 22315440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy.
    Cannon RO; Dilsizian V; O'Gara PT; Udelson JE; Schenke WH; Quyyumi A; Fananapazir L; Bonow RO
    Circulation; 1991 May; 83(5):1660-7. PubMed ID: 2022023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired coronary vasodilatory capacity after dipyridamole administration in hypertrophic cardiomyopathy.
    Shimamatsu M; Toshima H
    Jpn Heart J; 1987 May; 28(3):387-401. PubMed ID: 3626022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Left ventricular function in hypertrophic cardiomyopathy: a Tc-99m radionuclide angiographic study during exercise].
    Takahashi H; Yamaguchi R; Ifuku M; Itaya M; Koga Y; Utsu F; Toshima H; Takagi M; Hirashima M; Shimogawa Y
    J Cardiogr Suppl; 1986; (8):63-73. PubMed ID: 3722881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intracoronary dipyridamole infusion on regional myocardial blood flow and intrinsic thallium-201 washout in dogs with a critical coronary stenosis.
    Beller GA; Granato JE; Cannon JM; Belardinelli L; Watson DD
    Am Heart J; 1992 Jul; 124(1):56-64. PubMed ID: 1615828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of transient dilation of the left ventricular cavity in patients with hypertrophic cardiomyopathy by exercise thallium-201 scintigraphy].
    Sugihara H; Shiga K; Umamoto I; Harada Y; Katahira T; Nakagawa T; Matsubara K; Nakamura T; Terashima S; Azuma A
    Kaku Igaku; 1990 Nov; 27(11):1281-9. PubMed ID: 2290196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of dipyridamole Tl-201 emission computed tomography perfusion abnormality for evaluating pathophysiological and pathological aspects in hypertrophic cardiomyopathy.
    Mori T; Yamabe H; Yokota Y; Fukuzaki H
    Jpn Circ J; 1988 Feb; 52(2):111-8. PubMed ID: 3258928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of washout rate in patients with chronic renal failure by dipyridamole 201Tl myocardial scintigraphy--comparison with hypertrophic cardiomyopathy].
    Matsumura K; Senda Y; Ito T; Mizutani Y; Yoshida N; Yasuda R; Takagi I; Nakagawa T
    Kaku Igaku; 1993 Nov; 30(11):1405-9. PubMed ID: 8277603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The radionuclide diagnosis of dilated cardiomyopathy: a new approach to assessing myocardial perfusion function by 201Tl scintigraphic data at rest and during the performance of the dipyridamole test].
    Saidova MA; Ostroumov EN; Naumov VG; Sergienko VB; Belenkov IuN
    Kardiologiia; 1992 Jul; 32(7-8):50-5. PubMed ID: 1487882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.